genetics

Exclusive By Megan Molteni

Six patients with dementia went to Mexico for an unproven gene therapy, a biotech CEO claims

In the Lab By Kate Sheridan

HHS to prioritize newborn screening programs’ pipette tip orders

Exclusive By Erin Brodwin

With $12 million in new funding, data-syncing platform Seqster takes aim at health records

Biotech By Megan Molteni

Beam Therapeutics unveils new CRISPR base editing tool to target the sickle cell mutation

Health By Eric Boodman

Virtual Event: What gene-targeted therapies mean for patients with cancer

First Opinion By James Crawford, Jonathan Slotkin, and Meg Wyatt

To stem the pandemic, the U.S. needs a national Covid-19 genomic sequencing effort

Biotech By Damian Garde

STAT+ Conversations: A conversation on the future of gene therapy

First Opinion Podcast By Patrick Skerrett

Listen: Walter Isaacson on CRISPR rivals and a Covid truce

Biotech By Elizabeth Cooney

Novartis and the Gates Foundation aim to create a more practical gene therapy for sickle cell patients around the world

In the Lab By Theresa Gaffney

Studying brain organoids with a Neanderthal gene, scientists unlock clues to modern human evolution 

Health Tech By Katie Palmer

Scientists turn to machine learning to tackle one of gene therapy’s biggest challenges

Health By Andrew Joseph

‘What other variants might be out there?’ An expert on viral evolution on what’s happening with coronavirus mutations

Health Tech By Erin Brodwin and Katie Palmer

5 burning questions on the business of big genetics based on 23andMe’s filing to go public

The Readout LOUD By Damian Garde, Meg Tirrell, and Adam Feuerstein

Listen: 23andMe is going public, vaccine data abound, and Merck’s CEO is retiring

Health Tech By Matthew Herper

The Pajama Interview: A conversation with Anne Wojcicki and Richard Branson

Health Tech By Casey Ross and Matthew Herper

23andMe to go public via Richard Branson’s SPAC

Heavyweights By Lev Facher

Eric Lander is brilliant, connected, and controversial. Now Joe Biden wants him to ‘reinvigorate’ American science

The Readout LOUD By Damian Garde, Meg Tirrell, and Adam Feuerstein

Listen: JPM21: Déjà vu in Alzheimer’s research, debatable valuations in biotech, and OWS’s legacy

First Opinion By Chris Bakerlee

Mother Nature is not ‘the ultimate bioterrorist’

In the Lab By Sharon Begley

CRISPR cures progeria in mice, raising hope for one-time therapy for a disease that causes rapid aging

Health By Elizabeth Cooney

FDA approves genetically altering pigs, to potentially make food, drugs, and transplants safer

In the Lab By Eric Boodman

Genetic reprogramming rejuvenates nerve cells and restores vision in mice

Health By Nicholas St. Fleur

Leading genetics experts call for more racial representation in their industry

Biotech By Meghana Keshavan

Gene therapy pioneer develops a new approach to curb the side effects of treatment

Health Tech By Casey Ross

A boy’s passing came too soon, but not before his life led to crucial medical discoveries